Cargando…

Behavioral, Psychiatric, and Cognitive Adverse Events in Older Persons Treated with Glucocorticoids

Background: Since the introduction of glucocorticoids (GCs) in the physician’s pharmacological arsenal, it has been known that they are a cause of behavioral or psychiatric adverse events (BPAE), as well as of cognitive problems. To the best of our knowledge, the relationship between these adverse e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manzo, Ciro, Serra-Mestres, Jordi, Castagna, Alberto, Isetta, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163472/ https://www.ncbi.nlm.nih.gov/pubmed/30071590 http://dx.doi.org/10.3390/medicines5030082

Ejemplares similares

Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?
por: Manzo, Ciro, et al.
Publicado: (2021)

Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature
por: Manzo, Ciro, et al.
Publicado: (2022)

Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update
por: Manzo, Ciro, et al.
Publicado: (2023)

Cognitive Function in Primary Sjögren’s Syndrome: A Systematic Review
por: Manzo, Ciro, et al.
Publicado: (2019)

Depression and depressive symptoms in patients with polymyalgia rheumatica: discussion points, grey areas and unmet needs emerging from a systematic review of published literature
por: Manzo, Ciro, et al.
Publicado: (2020)

The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future Scenarios
por: Manzo, Ciro, et al.
Publicado: (2022)

Absence of Long-Lasting Morning Stiffness at the Time of Diagnosis as Paraneoplastic Warning in Patients with Polymyalgia Rheumatica (PMR): Data from Italian Single-Center Study
por: Manzo, Ciro, et al.
Publicado: (2023)

Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature
por: Manzo, Ciro, et al.
Publicado: (2020)

Polymyalgia rheumatica as uncommon adverse event following immunization with COVID‐19 vaccine: A case report and review of literature
por: Manzo, Ciro, et al.
Publicado: (2021)

Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: A Narrative Review
por: Wisidagama, Sharadha, et al.
Publicado: (2021)

Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
por: Manzo, Ciro, et al.
Publicado: (2021)

Catatonia in older adults: A systematic review
por: Jaimes-Albornoz, Walter, et al.
Publicado: (2022)

Hydroxychloroquine and QT Prolongation in Older Patients with Rheumatic Diseases: Who is afraid of the Boogeyman? We are not!
por: Castagna, Alberto, et al.
Publicado: (2020)

Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
por: Manzo, Ciro
Publicado: (2021)

Subjective sleep disturbances at the time of diagnosis in patients with polymyalgia rheumatica and in patients with seronegative elderly-onset rheumatoid arthritis. A pilot study
por: Manzo, Ciro, et al.
Publicado: (2020)

Adalimumab-Induced Rhupus Syndrome in a Female Patient Affected with Anti-Citrullinated Protein Antibody (ACPA)-Positive Rheumatoid Arthritis (RA): A Case Report and Review of Literature
por: Manzo, Ciro, et al.
Publicado: (2021)

Psychomotor Agitation Following Treatment with Hydroxychloroquine
por: Manzo, Ciro, et al.
Publicado: (2017)

Liver involvement in polymyalgia rheumatica and giant cell arteritis
por: Hysa, Elvis, et al.
Publicado: (2020)

Progress in the risk assessment of hydroxychloroquine in frail elderly people
por: Castagna, Alberto, et al.
Publicado: (2020)

Not just pain and morning stiffness duration in the daily experience of patients with polymyalgia rheumatica. Does the rheumatologist listen to all patient-reported outcomes?
por: Manzo, Ciro, et al.
Publicado: (2021)

Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?
por: Manzo, Ciro, et al.
Publicado: (2021)

Is the absence of prolonged morning stiffness at the time of diagnosis of polymyalgia rheumatica a paraneoplastic warning?
por: Manzo, Ciro, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on the spontaneous reporting and signal detection of adverse drug events
por: Montes-Grajales, Diana, et al.
Publicado: (2023)

Recognizing Catatonia in Medically Hospitalized Older Adults: Why It Matters
por: Serra-Mestres, Jordi, et al.
Publicado: (2018)

Answer to Cadiou et al. “SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger?”. Joint Bone Spine 2021;88:105282
por: Manzo, Ciro, et al.
Publicado: (2022)

Chloroquine: Psychiatric adverse events: case report
Publicado: (2020)

Adverse events in older adults and the risk of dementia and cognitive decline
por: Nilaweera, Dinuli, et al.
Publicado: (2023)

Older Couples Coping With Adverse Life Events: The Importance of Dyadic Personality Profiles
por: Wang, Shuangshuang, et al.
Publicado: (2020)

Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study
por: Ayani, Nobutaka, et al.
Publicado: (2021)

Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
por: Emmanuel, Stip, et al.
Publicado: (2020)

COVID-19 vaccine-related psychiatric adverse events: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Borderline personality disorder: associations with psychiatric disorders, somatic illnesses, trauma, and adverse behaviors
por: Tate, Ashley E., et al.
Publicado: (2022)

Healthcare Costs of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis
por: Best, Jennie H, et al.
Publicado: (2019)

Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel
por: Ettinger, Alan B., et al.
Publicado: (2015)

COVID-19 vaccine-related psychiatric adverse events: Mechanisms and considerations
por: Mopuru, Ranesh, et al.
Publicado: (2023)

Fever Correlation with Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentrations in Patients with Isolated Polymyalgia Rheumatica (PMR): A Retrospective Comparison Study between Hospital and Out-of-Hospital Local Registries
por: Manzo, Ciro, et al.
Publicado: (2022)

Older Candidates for Subthalamic Deep Brain Stimulation in Parkinson's Disease Have a Higher Incidence of Psychiatric Serious Adverse Events
por: Cozac, Vitalii V., et al.
Publicado: (2016)

Clinical outcome and predictors of adverse events of an enhanced older adult psychiatric liaison service: Rapid Assessment Interface and Discharge (Newport)
por: Singh, Inderpal, et al.
Publicado: (2016)

Adverse Drug Events in Patients with Dementia and Neuropsychiatric/Behavioral, and Psychological Symptoms, a One-Year Prospective Study
por: Hernández, Marta H., et al.
Publicado: (2019)

HLA-A*11:01 is associated with levetiracetam-induced psychiatric adverse events
por: Yang, Tae-Won, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5r59pv42fdthuc9jk2o387ah8q